Sperm Pre-Treatment may boost IVF success and cut miscarriages
NCT ID NCT02271490
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether triggering the sperm's acrosome reaction (a natural process that releases enzymes to help fertilize an egg) before doing ICSI (a type of IVF) could improve pregnancy outcomes. Researchers enrolled 111 couples undergoing their first ICSI cycle with at least 6 eggs. The goal was to see if this pre-treatment reduces early pregnancy loss and improves the chance of a healthy baby.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACROSOME REACTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Cochin
Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smart monitor help pregnant women with diabetes have healthier babies?
- Bed rest for short cervix under scrutiny: could normal activity be better?
- New IVF study tests calcium boosters for fertilization failures
- Labelled 'Abnormal' but born healthy? new study tests embryo genetic test accuracy
- AI could predict which sperm will lead to a baby
- NIH launches pregnancy registry to monitor research product safety